Literature DB >> 28965186

Weight gain since age of 20 as risk of metabolic syndrome even in non-overweight individuals.

Yoshitaka Hashimoto1, Masahide Hamaguchi2, Takuya Fukuda1, Akihiro Obora3, Takao Kojima3, Michiaki Fukui1.   

Abstract

PURPOSE: Metabolic syndrome (MetS), regardless of the presence of obesity, is known as a risk of diabetes and cardiovascular disease. Weight gain after age 20 reported to be associated with these diseases. Impact of the difference between the body mass index (BMI) at examination and BMI at age 20 (ΔBMIexa-20y) on MetS, especially in non-overweight individuals, remains to be elucidated.
METHODS: We analyzed the data of 24,363 individuals (14,301 men and 10,062 women) in this cross-sectional study. The diagnosis of MetS was diagnosed when three or more of the following criteria were present: hypertension, hyperglycemia, hypertriglyceridemia, low HDL-cholesterol level, and abdominal obesity. Logistic regression was performed to calculate odds ratios (ORs) and 95% confidence intervals (CIs) adjusting for age, alcohol, smoking, exercise, and BMI at examination.
RESULTS: Compared to the lowest ΔBMIexa-20y tertile (ΔBMIexa-20y < 1.2 kg/m2 in men and ≤0 kg/m2 in women), the highest tertile (ΔBMIexa-20y ≥ 3.2 kg/m2 in men and ≥2.0 kg/m2 in women) was associated with the risk of the presence of MetS (multivariate OR = 1.80, 95%CI 1.53-2.11, p < 0.001 in men and OR = 3.27, 95%CI 2.22-4.96, p < 0.001 in women). This result was also applicable in non-overweight individuals (multivariate OR = 2.06, 95%CI 1.46-2.92, p < 0.001 in men and OR = 2.49, 95%CI 1.40-4.64, p < 0.001 in women).
CONCLUSIONS: Our analyses showed that ΔBMIexa-20y is associated with the risk of the presence of MetS, even in non-overweight individuals. It is thus important to check weight changes from early adulthood, even in non-overweight individuals.

Entities:  

Keywords:  Epidemiology; Lean body mass; Metabolic syndrome; Obesity; Weight change

Mesh:

Substances:

Year:  2017        PMID: 28965186     DOI: 10.1007/s12020-017-1411-5

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  40 in total

1.  Long-term memory of body weight and past weight satisfaction: a longitudinal follow-up study.

Authors:  V A Casey; J T Dwyer; C S Berkey; K A Coleman; J Gardner; I Valadian
Journal:  Am J Clin Nutr       Date:  1991-06       Impact factor: 7.045

2.  The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children.

Authors:  F Sentinelli; L Bertoccini; I Barchetta; D Capoccia; M Incani; M G Pani; S Loche; F Angelico; M Arca; S Morini; E Manconi; A Lenzi; E Cossu; F Leonetti; M G Baroni; M G Cavallo
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-02-19       Impact factor: 4.222

3.  Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study.

Authors:  Renée de Mutsert; Qi Sun; Walter C Willett; Frank B Hu; Rob M van Dam
Journal:  Am J Epidemiol       Date:  2014-04-30       Impact factor: 4.897

Review 4.  Metabolic syndrome and kidney disease: a systematic review and meta-analysis.

Authors:  George Thomas; Ashwini R Sehgal; Sangeeta R Kashyap; Titte R Srinivas; John P Kirwan; Sankar D Navaneethan
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

5.  Metabolic health and weight: Understanding metabolically unhealthy normal weight or metabolically healthy obese patients.

Authors:  Hannah Mathew; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2015-10-23       Impact factor: 8.694

6.  Sarcopenia is associated with albuminuria independently of hypertension and diabetes: KNHANES 2008-2011.

Authors:  Eugene Han; Yong-Ho Lee; Gyuri Kim; So Ra Kim; Byung-Wan Lee; Eun Seok Kang; Chul Woo Ahn; Bong-Soo Cha
Journal:  Metabolism       Date:  2016-07-08       Impact factor: 8.694

7.  Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children.

Authors:  Rosellina M Mancina; Federica Sentinelli; Michela Incani; Laura Bertoccini; Cristina Russo; Stefano Romeo; Marco G Baroni
Journal:  Dig Liver Dis       Date:  2015-10-13       Impact factor: 4.088

8.  Metabolically healthy obesity, presence or absence of fatty liver, and risk of type 2 diabetes in Japanese individuals: Toranomon Hospital Health Management Center Study 20 (TOPICS 20).

Authors:  Yoriko Heianza; Yasuji Arase; Hiroshi Tsuji; Kazuya Fujihara; Kazumi Saito; Shiun Dong Hsieh; Shiro Tanaka; Satoru Kodama; Shigeko Hara; Hirohito Sone
Journal:  J Clin Endocrinol Metab       Date:  2014-05-13       Impact factor: 5.958

9.  Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study.

Authors:  Yukiko Fukuda; Yoshitaka Hashimoto; Masahide Hamaguchi; Takuya Fukuda; Naoto Nakamura; Akihiro Ohbora; Takahiro Kato; Takao Kojima; Michiaki Fukui
Journal:  Liver Int       Date:  2015-11-05       Impact factor: 5.828

10.  Body composition changes and cardiometabolic benefits of a balanced Italian Mediterranean Diet in obese patients with metabolic syndrome.

Authors:  Nicola Di Daniele; Luigi Petramala; Laura Di Renzo; Francesca Sarlo; Domenico Giovanni Della Rocca; Mariagiovanna Rizzo; Valentina Fondacaro; Leonardo Iacopino; Carl J Pepine; Antonino De Lorenzo
Journal:  Acta Diabetol       Date:  2012-11-28       Impact factor: 4.280

View more
  6 in total

1.  Derivation and Validation of a Prediction Model for Predicting the 5-Year Incidence of Type 2 Diabetes in Non-Obese Adults: A Population-Based Cohort Study.

Authors:  Xin-Tian Cai; Li-Wei Ji; Sha-Sha Liu; Meng-Ru Wang; Mulalibieke Heizhati; Nan-Fang Li
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-11       Impact factor: 3.168

2.  Understanding of antidiabetic medication is associated with blood glucose in patients with type 2 diabetes: At baseline date of the KAMOGAWA-DM cohort study.

Authors:  Ryosuke Sakai; Yoshitaka Hashimoto; Emi Ushigome; Takuro Okamura; Masahide Hamaguchi; Masahiro Yamazaki; Yohei Oda; Michiaki Fukui
Journal:  J Diabetes Investig       Date:  2018-09-24       Impact factor: 4.232

3.  The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.

Authors:  Aya Kitae; Yoshitaka Hashimoto; Masahide Hamaguchi; Akihiro Obora; Takao Kojima; Michiaki Fukui
Journal:  Can J Gastroenterol Hepatol       Date:  2019-10-07

4.  Body Mass Index and Its Change from Adolescence to Adulthood Are Closely Related to the Risk of Adult Metabolic Syndrome in China.

Authors:  Bingyang Liu; Yue Li; Jiamei Guo; Yuting Fan; Ling Li; Ping Li
Journal:  Int J Endocrinol       Date:  2021-02-18       Impact factor: 3.257

5.  Association Between METS-IR and Prehypertension or Hypertension Among Normoglycemia Subjects in Japan: A Retrospective Study.

Authors:  Kai-Yue Han; Jianing Gu; Zhangsheng Wang; Jie Liu; Su Zou; Chen-Xi Yang; Dan Liu; Yingjia Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-18       Impact factor: 5.555

6.  Association Between the Triglyceride-Glucose Index and the Incidence of Diabetes in People With Different Phenotypes of Obesity: A Retrospective Study.

Authors:  Su Zou; Chenxi Yang; Rui Shen; Xiang Wei; Junwen Gong; Yali Pan; Yang Lv; Yingjia Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.